Wataru Okamoto

Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies

Yoshiaki Nakamura, Hiroya Taniguchi, Masafumi Ikeda et al. · Nature Medicine · 2020 · 366 citations

Medicine, Molecular Genetics, Oncology +17

Circulating tumor DNA-guided treatment with pertuzumab plus trastuzumab for HER2-amplified metastatic colorectal cancer: a phase 2 trial

Yoshiaki Nakamura, Wataru Okamoto, Takeshi Kato et al. · Nature Medicine · 2021 · 244 citations · Full text

Medicine, Molecular Medicine, Oncology +17

TAS-102 plus bevacizumab for patients with metastatic colorectal cancer refractory to standard therapies (C-TASK FORCE): an investigator-initiated, open-label, single-arm, multicentre, phase 1/2 study

Yasutoshi Kuboki, Tomohiro Nishina, Eiji Shinozaki et al. · The Lancet Oncology · 2017 · 175 citations

Medicine, Oncology, Pharmacology +9

Thymidylate synthase as a determinant of pemetrexed sensitivity in non-small cell lung cancer

Ken Takezawa, Isamu Okamoto, Wataru Okamoto et al. · British Journal of Cancer · 2011 · 169 citations · Full text

Medicine, Oncology, Pharmacology +13

Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing unresectable or recurrent biliary tract cancer (BTC): An investigator-initiated multicenter phase 2 study (HERB trial).

Akihiro Ohba, Chigusa Morizane, Yasuyuki Kawamoto et al. · Journal of Clinical Oncology · 2022 · 107 citations

Medicine, Cancer Biology, Oncology +17